Michael Bronze to Carcinoma, Renal Cell
This is a "connection" page, showing publications Michael Bronze has written about Carcinoma, Renal Cell.
Connection Strength
0.139
-
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. Int J Cancer. 2018 09 01; 143(5):1162-1175.
Score: 0.139